| |
The
history of our parent Company, Terumo Corporation, spans an even greater
period in medical device development. In the early 1920's, a group of
Japanese doctors responded to the shortage of medical equipment in Japan
by forming a company to develop a superior clinical thermometer for domestic
distribution. That company later became Terumo Corporation. It has continued
to grow and is now one of the largest suppliers of medical devices in
Japan.
1921 Foundation of the Company
1922 Introduction
of the first clinical themometer
1964 Launch
of disposable hypodermic syringes
1969 Production
and launch of blood bags
1971 Terumo
America is founded in the USA, Terumo Europe is founded in Belgium
1981 Introduction
of the first hollow fiber oxygenator
1985 Introduction
of Terumo Hydrophilic Guidewire
1986 Commercialisation
of Terumo PTCA Catheter
1999 Terumo
aquires the Sarns and CDI brands from 3M and founded Terumo Cardiovascular
Systems (USA)
2000 Launch
of Tsunami, Tsunami, TerumoCoronary Stent
2001 Terumo
Cardiovascular Systems aquires the Lifestream International Inc, Cannulae
Division
2002 Acquisition
of Vascutek Ltd, a global leader in artificialvascular grafts
2002
Introduction of Capiox®Baby RX™ Neonatal Oxygenator and of Terumo
Advanced Perfusion System 1 in Europe.
2003 Launch
of Venosafe produced by Terumo Europe
2003
Global Distribution agreement with Biocompatibles for BeadBlock (Embolosation)
2003 Terumo forms a wholly owned subsidiary, Terumo Heart
Inc, to develop an implantable left ventricular assist device (Duraheart)
2003 Licensing Agreement with Biosensors for development
of a Drug Eluting Stent
2004 Introduction
of the Khuri Myocardial pH Monitoring System in Europe
2005 Nobori
1, clinical program for NOBORI™ DRUG-ELUTING STENT
2005
Terumo Corporation plans to launch a syringe for insulin patients featuring
the world's smallest needle
2006 Terumo
Europe N.V. opens Representative Office in Moscow
2007 Terumo
receives CE Certificate for NOBORI™ DRUG-ELUTING STENT
2008 Terumo
receives CE Certificate for NOBORI™ DRUG-ELUTING STENT
2008
Terumo Announces First CE Certified NOBORI™ DES in Use
2008
Terumo Opens Office in Switzerland
|
|
| Terumo Europe N.V. |
| Founded |
1971 |
| President |
Hideo Arase |
Sales
|
€ 285 million (FY ’06)
€ 250 million (FY ’05)
€ 237 million (FY ’04)
|
| Employees |
945 |
Operations
|
Manufacturing, exporting, importing, marketing and sales of medical
products and devices |
Products
|
Over 1,500 products including perfusion circuits, pumping systems, cannulae & catheters
for cardiovascular surgery, guidewires, catheters for interventional
procedures, stents, PTA and PTCA balloons, syringes, hypodermic needles,
IV catheters, blood collection systems, blood bags, sterile connecting
systems |
Headquarter
|
Researchpark Zone 2 Haasrode
Interleuvenlaan 40 / B-3001 Leuven, Belgium |
Manufacturing
|
Haasrode Plant: 27 000 square meters
Daily production: 1.5 million of syringes, 4.5 million of needles, 1 million
of blood tubes, 700,000 needles for blood tubes
Uk Plant: 300 square meters, production of tubing packs for cardiovascular surgery |
Investment
|
Terumo Europe NV stock is not publicly traded on The Brussels Stock
Exchange. However, Terumo Corporation, the parent Company of TE, is
publicly traded on the Tokyo Stock Exchange. On April 24, 2000, Terumo
Corporation became one of 225 companies to form the Nikkei Average
on the Tokyo Stock Exchange. |
Terumo® Europe
NV manufactures, exports, imports, markets and sells a wide range
of quality products for angiography, cardiology and cardiovascular systems,
transfusion,
clinical test systems and patient monitoring which comply with the highest
standards in the medical world and constantly contribute to the healthcare
of people in
Europe.
Terumo Europe was founded in 1971 and generates € 250 million in
annual sales (FY ’05). While some products and devices sold by
the company are produced in Japan and in the United States, a part of
them are manufactured by Terumo Europe in Belgium (syringes, needles,
vacuum tubes, catheters and introducers for interventional radiology)
and in UK (custom tubing packs for Open heart surgery).
Terumo’s state-of-the-art manufacturing facilities in Haasrode,
Belgium make extensive use of automated processes and systems. Their Quality
system is
certified to the ISO9001 Standard. Terumo’s superior manufacturing
processes are a vivid example of the success that can be attained when
people focus on
quality. We apply the strictest standards of quality and control to
every item we manufacture.
Rightly, the healthcare community demands products
they can depend upon to deliver the expected benefit, time after
time, with no variance. Terumo
delivers
this
performance – dependably, predictably, and consistently.
|
|
 |